Objective: To compare the TNM and Ann Arbor staging systems in predicting outcome in ocular adnexal lymphoma (OAL).
Methods: Retrospective review of the clinical, imaging and histopathologic records of OALs between 1986 and 2009. Outcome measures included local recurrence and progression.
Results: One hundred and sixty patients of OAL were included. Mean age was 65 ± 15 years (range 20-97) and 68 (43%) were male. The median follow-up of all OAL patients was 65 months (range 2.5-238). Histopathology identified low-grade, indolent B-cell lymphomas in 140 patients (87.5%) and rest had aggressive grades. Of 134 indolent OAL patients, those with unilateral disease had a 10-year progression free survival of 72% versus 48% in their bilateral counterparts (p = 0.001). Amongst unilateral OAL patients staged within the T1-2 group, a significantly better outcome was noted for patients without nodal or metastatic involvement compared to those with such involvement (p = 0.0001). The above observations helped to formulate a simple scoring system to prognosticate OALs based on their laterality and node/metastatic status. Amongst the 3 groups identified, group 1 with a score of 0 (unilateral OALs with no nodes or metastasis) had a 10-year progression free survival of 75%; group 2 with score 1 (either bilateral or positive nodes/metastasis) 50% and group 3 with score 2 (both bilateral OAL with positive nodes/metastasis) zero at 10 years (p < 0.00001).
Conclusions: The TNM-based staging system better predicts outcome in OAL than the Ann Arbor system primarily by delineation of bilateral disease and nodal/metastatic involvement at presentation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/01676830.2013.842257 | DOI Listing |
Indian J Ophthalmol
December 2024
Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.
Purpose: This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients' survival outcomes.
Methods: A total of 123 patients were included in the study; of these, 93 patients were selected for survival analysis. Survival data were analyzed using the Kaplan-Meier test, and correlation was assessed through the log-rank test and Cox regression analysis.
Eur Radiol
December 2024
Xi'an Key Lab of Radiomics and Intelligent Perception, School of Information Science and Technology, Northwest University, Xi'an, China.
Objectives: To evaluate the value of deep-learning-based intratumoral and peritumoral features for differentiating ocular adnexal lymphoma (OAL) and idiopathic orbital inflammation (IOI).
Methods: Nighty-seven patients with histopathologically confirmed OAL (n = 43) and IOI (n = 54) were randomly divided into training (n = 79) and test (n = 18) groups. DL-based intratumoral and peritumoral features were extracted to characterize the differences in heterogeneity and tissue invasion between different lesions, respectively.
Rev Recent Clin Trials
October 2024
Clinical Research Development Unit of Shahid Beheshti Hospital, Hamadan University of Medical Science, Hamadan, Iran.
Background: Helicobacter pylori [H. pylori] infection is the main cause of most PUD; therefore, the eradication of H. pylori is extremely important in the treatment of PUD.
View Article and Find Full Text PDFAJNR Am J Neuroradiol
September 2024
From Penn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics (ARM, MLM, TRF, QC, CMO, RTS), the Department of Neurology (ABO, RDS, MKS), the Department of Radiology (MB, JWS), and the Center for Biomedical Image Computing and Analytics (RTS), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA; Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke (VL, LD, OAL, DSR, PS) and Section on Functional Imaging Methods, Laboratory of Brain and Cognition (JD), National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA; Department of Neurology (EG, BR, NLS, OAL, PS), Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cleveland Clinic Lerner College of Medicine (PR, LD) and Mellen Center for Multiple Sclerosis (DO), Cleveland Clinic, Cleveland, OH, United States of America; QMENTA Inc. (PR, MR), Boston, MA, United States; Department of Neurology (CA, DP), University of Southern California, Los Angeles, CA, USA; UCSF Weill Institute for Neurosciences, Department of Neurology (EC, BAC, RGH, NP), University of California San Francisco, San Francisco, CA, USA; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Neuroradiology Department, Advanced Imaging and Radiomics Center (EC), IRCCS Mondino Foundation, Pavia, Italy; Department of Neurology (PAC, ESS), Johns Hopkins University, Baltimore, MD, USA; Department of Neurology (LF), Dell Medical School, The University of Texas at Austin, TX, USA; Department of Neurology (EEL), Yale University, New Haven, CT, USA; Division of Neurology, Department of Medicine (JO), and the Department of Medical Imaging (SS), St. Michael's Hospital, University of Toronto, Canada; Department of Neurological Sciences (AJS), Larner College of Medicine at The University of Vermont, Burlington, VT, USA.
Handb Clin Neurol
September 2024
Unit of Pediatric Neurology, Department of Biomedical and Clinical Sciences, V. Buzzi Children's Hospital, Università degli Studi di Milano, Milan, Italy; C.O.A.L.A (Center for Diagnosis and Treatment of Leukodystrophies), V. Buzzi Children's Hospital, Università degli Studi di Milano, Milan, Italy. Electronic address:
Hypomyelination is defined by the evidence of an unchanged pattern of deficient myelination on two MRIs performed at least 6 months apart in a child older than 1 year. When the temporal criteria are not fulfilled, and the follow-up MRI shows a progression of the myelination even if still not adequate for age, hypomyelination is excluded and the pattern is instead consistent with delayed myelination. This can be mild and nonspecific in some cases, while in other cases there is a severe delay that in the first disease stages could be difficult to differentiate from hypomyelination.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!